The Chicago Entrepreneur

Dow Jones Newswires: FDA approves Innoviva’s bacterial pneumonia treatment

The Food and Drug Administration said Tuesday that it approved Innoviva’s Xacduro pneumonia treatment, which fights the Acinetobacter bacteria.

Previous post Dow Jones Newswires: RBNZ announces another rate hike as cyclone cleanup lifts economy
Next post Dow Jones Newswires: Rocket Lab agrees to pay $16 million for portion of Virgin Orbit assets